Key facts
- Notable investors include Guizhou Financial Holdings Group.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Green Field Chinese Medicinal Materials Development
- ·The full record, as it builds
Funding rounds
No funding rounds for Green Field Chinese Medicinal Materials Development are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Green Field Chinese Medicinal Materials Development
Producer of Chinese medicinal materials aims to promote ecological sustainability and rural revitalization. The company's offerings feature an integrated industrial chain covering TCM seedling cultivation, planting, processing, and sales, leveraging a long-term and short-term planting model with species through advanced agricultural practices, collaboration with research institutions, and partnerships with pharmaceutical companies, enabling improved product quality, stable sales channels, increased local employment, and the harmonious development of the forest economy and rural industries.
- Sector
- Materials and Resources
- HQ
- Anshun, China
- Founded
- 2020
- Employees
- 7
- Ownership
- Privately Held (backing)
Green Field Chinese Medicinal Materials Development doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Green Field Chinese Medicinal Materials Development shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Green Field Chinese Medicinal Materials Development in its N-PORT filings yet. We sweep new filings monthly.